# FDA 483 - Department of Defense - Navy - March 04, 2026

Source: https://www.keypedia.com/records/483/department-of-defense-navy/879fed92-7024-42d0-ad39-81eddbbbc791

> FDA 483 for Department of Defense - Navy on March 04, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Department of Defense - Navy
- Inspection Date: 2026-03-04
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - West VI
- Summary: An FDA inspection of the Department of Defense - Navy's Hospital Blood Bank in Agana Heights, GU, revealed a significant failure in donor screening procedures. The firm did not consistently obtain confirmation from donors regarding their postal address for 8 weeks post-donation, a critical requirement for donor traceability. This issue was observed during donor screenings and was also noted as a deficiency in the firm's standard operating procedures.

## Related Officers

- [FDA_PERSONNEL](https://www.keypedia.com/people/maurine-fadlalla/519e6e71-a50a-43b5-b41a-2249ec9afdd5)

Company: https://www.keypedia.com/companies/department-of-defense-navy/3d5371bb-4187-4b51-a51a-6c13f8806f47

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-vi/6e5a2a08-f464-4979-a759-7b0383370822